Liping Song

Title: Innovations of Liping Song in Tumor Treatment

Introduction

Liping Song is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic proteins. Her work focuses on creating solutions for tumor treatment, showcasing her dedication to advancing medical science.

Latest Patents

Liping Song holds a patent for a bispecific recombinant protein, which is designed to target tumors effectively. This innovative protein comprises a high affinity tumor-targeting arm and a low affinity fusion protein that blocks the interaction of CD47 with SIRPα. The antibody corresponding to the high affinity tumor-targeting arm does not bind to CD47, ensuring that its binding affinity to the target antigen on the tumor cell is at least six times greater than that of the monomer fusion protein homodimer. This groundbreaking invention also includes nucleic acid molecules encoding the recombinant proteins, which can be utilized in the manufacture of a medicament for treating tumors.

Career Highlights

Liping Song's career is marked by her commitment to research and innovation in the biotechnology sector. She has been instrumental in developing novel therapeutic approaches that have the potential to improve patient outcomes in cancer treatment. Her work exemplifies the intersection of scientific research and practical application in medicine.

Collaborations

Liping collaborates with talented individuals in her field, including Xiaotian Cui and Jian Wang. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in biotechnology.

Conclusion

Liping Song's contributions to the field of tumor treatment through her innovative bispecific recombinant protein highlight her role as a leading inventor in biotechnology. Her work not only advances scientific knowledge but also holds promise for improving therapeutic options for patients facing cancer.